Browsing Other ICR Research by author "Khoo, Vincent"
Now showing items 1-1 of 1
-
ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer.
Crabb, SJ; Birtle, AJ; Martin, K; Downs, N; Ratcliffe, I; et al. (2017-10)Background Docetaxel and prednisolone chemotherapy (DP) extends survival in metastatic castration resistant prostate cancer (mCRPC). However, emergent clinical resistance is almost inevitable. AKT pathway activation is ...